A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab

Patient: Female, 51-year-old Final Diagnosis: Diabetic ketoacidosis Symptoms: Abdominal pain • diarrhea Medication: Pembrolizumab Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Immune checkpoint inhibitors (ICIs) are a no...

Descripción completa

Detalles Bibliográficos
Autores principales: Kedzior, Sonya K., Jacknin, Gabrielle, Hudler, Andi, Mueller, Scott W., Kiser, Tyree Heath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255078/
https://www.ncbi.nlm.nih.gov/pubmed/34185763
http://dx.doi.org/10.12659/AJCR.931702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255078/
https://www.ncbi.nlm.nih.gov/pubmed/34185763
http://dx.doi.org/10.12659/AJCR.931702

Ejemplares similares